Global Angina Pectoris Treatment Market Report 2022 to 2030 - Featuring Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Novartis and Pfizer Among Others - ResearchAndMarkets.com

Source :: Business Wire. January 31, 2023
Publication Year :: 2023
Abstract: DUBLIN -- The 'Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030' report has been added to [...]

Subjects :: Bayer AG -- Forecasts and trends
GSK PLC -- Forecasts and trends
Gilead Sciences Inc. -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Forest Laboratories Inc. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Biological products industry -- Forecasts and trends
Angina pectoris -- Forecasts and trends
Ticagrelor -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
Business, international

Tools